U.S. Gastroretentive Drug Delivery Systems Market Size & Outlook
U.S. gastroretentive drug delivery systems market, 2016-2028 (US$M)
Related Markets
U.S. gastroretentive drug delivery systems market highlights
- The U.S. gastroretentive drug delivery systems market generated a revenue of USD 4,387.6 million in 2021 and is expected to reach USD 6,852.8 million by 2028.
- The U.S. market is expected to grow at a CAGR of 6.6% from 2022 to 2028.
- In terms of segment, floating drug delivery system and was the largest revenue generating type in 2021.
- Bioadhesive Drug Delivery System is the most lucrative type segment registering the fastest growth during the forecast period.
Gastroretentive drug delivery systems market data book summary
| Market revenue in 2021 | USD 4,387.6 million |
| Market revenue in 2028 | USD 6,852.8 million |
| Growth rate | 6.6% (CAGR from 2021 to 2028) |
| Largest segment | Floating drug delivery system and |
| Fastest growing segment | Bioadhesive Drug Delivery System |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Floating Drug Delivery System and, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High density systems |
| Key market players worldwide | Roche Holding AG ADR, GSK PLC, Alcon Inc, Ranbaxy Laboratories, Pharmacia, Lupin, Galaxy Digital Holdings Ltd, Sun Pharma Advanced Research Company |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.4% of the global gastroretentive drug delivery systems market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. gastroretentive drug delivery systems market is projected to lead the regional market in terms of revenue in 2028.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 6,852.8 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gastroretentive Drug Delivery Systems Market Scope
Gastroretentive Drug Delivery Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. gastroretentive drug delivery systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastroretentive drug delivery systems market will help companies and investors design strategic landscapes.
Floating drug delivery system and was the largest segment with a revenue share of 46.44% in 2021. Horizon Databook has segmented the U.S. gastroretentive drug delivery systems market based on floating drug delivery system and, expandable drug delivery system, bioadhesive drug delivery system, high density systems covering the revenue growth of each sub-segment from 2016 to 2028.
Reasons to subscribe to U.S. gastroretentive drug delivery systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. gastroretentive drug delivery systems market databook
-
Our clientele includes a mix of gastroretentive drug delivery systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gastroretentive drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into U.S. gastroretentive drug delivery systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. gastroretentive drug delivery systems market size, by type, 2016-2028 (US$M)
U.S. Gastroretentive Drug Delivery Systems Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
